KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Short-term Investments (2021 - 2025)

Historic Short-term Investments for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $18.5 million.

  • Bionano Genomics' Short-term Investments rose 6832.73% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 6832.73%. This contributed to the annual value of $11.0 million for FY2024, which is 7746.96% down from last year.
  • As of Q3 2025, Bionano Genomics' Short-term Investments stood at $18.5 million, which was up 6832.73% from $12.9 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Short-term Investments ranged from a high of $226.0 million in Q4 2021 and a low of $11.0 million during Q3 2024
  • In the last 5 years, Bionano Genomics' Short-term Investments had a median value of $48.8 million in 2023 and averaged $80.0 million.
  • Per our database at Business Quant, Bionano Genomics' Short-term Investments tumbled by 8230.4% in 2024 and then soared by 6832.73% in 2025.
  • Quarter analysis of 5 years shows Bionano Genomics' Short-term Investments stood at $226.0 million in 2021, then tumbled by 52.18% to $108.1 million in 2022, then tumbled by 54.83% to $48.8 million in 2023, then tumbled by 77.47% to $11.0 million in 2024, then surged by 68.33% to $18.5 million in 2025.
  • Its last three reported values are $18.5 million in Q3 2025, $12.9 million for Q2 2025, and $14.6 million during Q1 2025.